Harriet L. Robinson

14.3k citations

192 papers · 11.3k indexed · 3 hit papers · h-index 59

Virology top 0.1%
- HIV Research and Treatment 78
Immunology top 0.2%
- Immunotherapy and Immune Responses 61
- Immune Cell Function and Interaction 47
- T-cell and B-cell Immunology 26
Infectious Diseases top 0.5%
Animal Science and Zoology top 0.2%
- Animal Virus Infections Studies 34
Epidemiology top 0.5%
- Herpesvirus Infections and Treatments 41
Molecular Biology
- vaccines and immunoinformatics approaches 24
Genetics
- Virus-based gene therapy research 20

Co-authors: Robert G. Webster Rama Rao Amara Ellen F. Fynan Joel R. Haynes J C Santoro Deborah H. Fuller David C. Montefiori William H. Robinson
Cited by: Virology Immunology Infectious Diseases
Journals: Science (1 paper)Cell (3 papers)Proceedings of the National Academy of Sciences (6 papers)
Partner nations: United States Canada Australia

In The Last Decade

Harriet L. Robinson

189 papers receiving 10.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Harriet L. Robinson

Since Specialization

Citations

This map shows the geographic impact of Harriet L. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet L. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet L. Robinson more than expected).

Fields of papers citing papers by Harriet L. Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harriet L. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet L. Robinson. The network helps show where Harriet L. Robinson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Harriet L. Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harriet L. Robinson Line = papers co-authored together Harriet L. Robinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge Scientific Reports ·Arban Domi,Friederike Feldmann,Rahul Basu,Nathanael McCurley,Kyle Shifflett,Jackson Emanuel,Michael Hellerstein,Farshad Guirakhoo,Chiara Orlandi,Robin Flinko,George K. Lewis,Patrick W. Hanley,Heinz Feldmann,Harriet L. Robinson,Andrea Marzi	2018	33
2	A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model Scientific Reports ·Aaron C. Brault,Arban Domi,Erin McDonald,Dalit Talmi-Frank,Nathanael McCurley,Rahul Basu,Harriet L. Robinson,Michael Hellerstein,Nisha K. Duggal,Richard A. Bowen,Farshad Guirakhoo	2017	90
3	High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques The Journal of Immunology ·Sunil Kannanganat,Linda S. Wyatt,Sailaja Gangadhara,Venkatesarlu Chamcha,Lynette S. Chea,Pamela A. Kozlowski,Celia C. LaBranche,Lakshmi Chennareddi,Benton Lawson,Pradeep B. J. Reddy,Tiffany M. Styles,Thomas H. Vanderford,David C. Montefiori,Bernard Moss,Harriet L. Robinson,Rama Rao Amara	2016	12
4	The Immune Space: A Concept and Template for Rationalizing Vaccine Development AIDS Research and Human Retroviruses ·Amapola Manrique,Elizabeth M. Adams,Dan H. Barouch,Pat Fast,Barney S. Graham,Jérôme H. Kim,James G. Kublin,Margaret McCluskey,Giuseppe Pantaleo,Harriet L. Robinson,Nina D. Russell,W. F. Snow,Margaret I. Johnston	2014	10
5	SIVsmE660 Envelope Variants from Breakthrough Infections Following DNA/MVA Vaccination of Rhesus Macaques Are Susceptible to Neutralization AIDS Research and Human Retroviruses ·Stacey Abigail Smith,Samantha L. Burton,Sharmila Reddy,Katie M. Kilgore,Eric Hunter,Harriet L. Robinson,Rama Rao Amara,Cynthia A. Derdeyn	2014	1
6	DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge Virology ·Pragati Nigam,Patricia L. Earl,Jeffrey L. Americo,Sunita Sharma,Linda S. Wyatt,Yvette Edghill-Spano,Lakshmi Chennareddi,Peter Silvera,Bernard Moss,Harriet L. Robinson,Rama Rao Amara	2007	37
7	Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines Vaccine ·Linda S. Wyatt,Patricia L. Earl,Jennifer Vogt,Leigh Anne Eller,Dev Chandran,Jinyan Liu,Harriet L. Robinson,Bernard Moss	2007	40
8	HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges Virology ·Dennis Ellenberger,Ronald A. Otten,Bin Li,Michael Aidoo,Irma Rodriguez,Carlos A. Sariol,Melween I. Martínez,Michael Monsour,Linda S. Wyatt,Michael G. Hudgens,Edmundo Kraiselburd,Bernard Moss,Harriet L. Robinson,Thomas M. Folks,Salvatore T. Butera	2006	37
9	Short Communication : Studies in Macaques on Cross-Clade T Cell Responses Elicited by a DNA/MVA AIDS Vaccine, Better Conservation of CD8 Than CD4 T Cell Responses AIDS Research and Human Retroviruses ·James M. Smith,Rama Rao Amara,Linda S. Wyatt,Dennis Ellenberger,Bin Li,James G. Herndon,Milloni Patel,Sunita Sharma,Lakshmi Chennareddi,Sal Butera,Janet M. McNicholl,Harold M. McClure,Bernard Moss,Harriet L. Robinson	2005	8
10	Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques Virology ·Rama Rao Amara,Chris Ibegbu,François Villinger,David C. Montefiori,Sunita Sharma,Pragati Nigam,Yongxian Xu,Harold M. McClure,Harriet L. Robinson	2005	35
11	DNA/MVA Vaccine for HIV Type 1: Effects of Codon-Optimization and the Expression of Aggregates or Virus-Like Particles on the Immunogenicity of the DNA Prime AIDS Research and Human Retroviruses ·James M. Smith,Rama Rao Amara,David Campbell,Yan Xu,Milloni Patel,Sunita Sharma,Salvatore T. Butera,Dennis Ellenberger,Hong Yi,Lakshmi Chennareddi,James G. Herndon,Linda S. Wyatt,David C. Montefiori,Bernard Moss,Harold M. McClure,Harriet L. Robinson	2004	52
12	Multiprotein HIV Type 1 Clade B DNA and MVA Vaccines: Construction, Expression, and Immunogenicity in Rodents of the MVA Component AIDS Research and Human Retroviruses ·Linda S. Wyatt,Patricia L. Earl,Jin Yan Liu,James M. Smith,David C. Montefiori,Harriet L. Robinson,Bernard Moss	2004	30
13	Multiprotein HIV Type 1 Clade B DNA/MVA Vaccine: Construction, Safety, and Immunogenicity in Macaques AIDS Research and Human Retroviruses ·James M. Smith,Rama Rao Amara,Harold M. McClure,Milloni Patel,Sunita Sharma,Hong Yi,Lakshmi Chennareddi,James G. Herndon,Salvatore T. Butera,Walid Heneine,Dennis Ellenberger,Bharat Parekh,Patricia L. Earl,Linda S. Wyatt,Bernard Moss,Harriet L. Robinson	2004	48
14	DNA Vaccines, Combining Form of Antigen and Method of Delivery to Raise a Spectrum of IFN-γ and IL-4-Producing CD4+ and CD8+ T Cells The Journal of Immunology ·Alp E. Oran,Harriet L. Robinson	2003	53
15	Gp120-Alum Boosting of a Gag-Pol-Env DNA/MVA AIDS Vaccine: Poorer Control of a Pathogenic Viral Challenge AIDS Research and Human Retroviruses ·Suzan L. Buge,Hak‐Ling Ma,Rama Rao Amara,Linda S. Wyatt,Patricia L. Earl,François Villinger,David C. Montefiori,Silvija I. Staprans,Yan Xu,Eddye Carter,Shawn P. O’Neil,James G. Herndon,Elizabeth Hill,Bernard Moss,Harriet L. Robinson,Janet M. McNicholl	2003	28
16	New hope for an aids vaccine Nature reviews. Immunology ·Harriet L. Robinson	2002	103
17	DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses Vaccine ·Celia A.T Torres,Kejian Yang,Farah Mustafa,Harriet L. Robinson	1999	35
18	Increased oncogenic potential of ErbB is associated with the loss of a COOH-terminal domain serine phosphorylation site. Journal of Biological Chemistry ·Steven J. Theroux,C Taglienti-Sian,Nandini Nair,J L Countaway,Harriet L. Robinson,Roger J. Davis	1992	23
19	Fragile X syndrome without CCG amplification has an FMR1 deletion Nature Genetics ·Ági K. Gedeon,Emma K. Baker,Harriet L. Robinson,M. W. Partington,Bella Gross,Antonella Manca,Bernhard Korn,Annemarie Poustka,S. Yu,G.R. Sutherland,John C. Mulley	1992	167
20	Influence of avian leukosis viral sequences on transmission to the egg and embryo Virology ·David W. Brown,Harriet L. Robinson	1989	3

About Harriet L. Robinson

Harriet L. Robinson is a scholar working on Virology, Immunology and Animal Science and Zoology, having authored 192 papers that have together received 11.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (78 papers), Immunotherapy and Immune Responses (61 papers), Immune Cell Function and Interaction (47 papers), Herpesvirus Infections and Treatments (41 papers), Animal Virus Infections Studies (34 papers), T-cell and B-cell Immunology (26 papers), vaccines and immunoinformatics approaches (24 papers) and Virus-based gene therapy research (20 papers). The work is most often cited by research in Virology (3.5k citations), Immunology (5.3k citations) and Infectious Diseases (2.5k citations). Harriet L. Robinson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert G. Webster, Rama Rao Amara, Ellen F. Fynan, Joel R. Haynes, J C Santoro, Deborah H. Fuller, David C. Montefiori, William H. Robinson, Susan M. Astrin and Lee Hunt. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact